Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Actavis confirms $25 bln Forest Labs acquistion
Marketwatch
Tuesday, February 18, 2014 - 9:13am
tags:
Actavis, M&A, Forest Labs
2014 Could Be A Transformative Year For Apricus Biosciences
Seeking Alpha
Tuesday, February 18, 2014 - 9:11am
tags:
Apricus Biosciences, Vitaros, erectile dysfunction, Femprox, female sexual dysfunction
Enzymotec Had A Great 2013, And Has A Promising Year Ahead
Seeking Alpha
Tuesday, February 18, 2014 - 9:01am
tags:
Enzmotec, infant nutrtion
Galena CEO's Response to Stock Promotions Leaves Questions Unanswered
TheStreet.com
Tuesday, February 18, 2014 - 9:00am
tags:
Galena Biopharma, Pharma CEOs, Mark Ahn
Preclinical Study Results of Merrimack's MM-141 Published in Molecular Cancer Therapeutics
Yahoo/Benzinga
Tuesday, February 18, 2014 - 8:58am
tags:
Merrimack Pharmaceuticals, MM-141
3 Great Small-Cap Biotech Stocks: NeoStem, Pozen, Curis
Wall St Cheat Sheet
Tuesday, February 18, 2014 - 8:57am
tags:
NeoStem, Pozen, Curis
Medtronic posts lower earnings on charges
Yahoo/Reuters
Tuesday, February 18, 2014 - 8:56am
tags:
Medtronic, earnings, devices
FDA head says working with India to improve drug quality, safety
Yahoo/Reuters
Tuesday, February 18, 2014 - 8:55am
tags:
FDA, India, quality, drug manufacturing
Actavis in talks to buy Forest Labs for as much as $25 billion - WSJ
Yahoo/Reuters
Tuesday, February 18, 2014 - 8:54am
tags:
Actavis, Forest Labs, M&A
Big Pharma Continues the Race for Electroporation
Wall St Cheat Sheet
Monday, February 17, 2014 - 8:02pm
tags:
electroporation, Roche, Pfizer, Inovio, Ichor
BioMarin and its patient coaches are ready to roll on Vimizim launch
Fierce Pharma
Monday, February 17, 2014 - 7:48pm
tags:
Biomarin, Vimizim, drug launches
ViiV, Gilead sweep the pharma image competition--and Pfizer is close behind
Fierce Pharma
Monday, February 17, 2014 - 7:47pm
tags:
Gilead Sciences, ViiV, Pfizer
Can These 2 Health Care Giants Overcome Big Pharma's Alzheimer's Struggles?
Motley Fool
Monday, February 17, 2014 - 3:24pm
tags:
Alzheimer's disease, Merck, AstraZeneca, BACE inhibitors, MK-8931, AZD3293
Dow Debate: Will Pfizer Crush Merck?
Motley Fool
Monday, February 17, 2014 - 3:23pm
tags:
Pfizer, Merck
Poor Pipeline Management Imperils Lilly's Future Cash Flows
Motley Fool
Monday, February 17, 2014 - 3:22pm
tags:
Eli Lilly, diabetes, insulin, Novo Nordisk, Sanofi, oncology, Alzheimer's disease
Innovation In Huntington's Disease: Auspex Vs. Rivals
Seeking Alpha
Monday, February 17, 2014 - 3:20pm
tags:
Huntington's disease, Auspex Pharmaceuticals, SD-809
Is the Market Discounting Galena’s Acquisition of Mills?
Wall St Cheat Sheet
Monday, February 17, 2014 - 11:13am
tags:
Galena Biopharma, NeuVax, breast cancer, GALE-401
Rx For Software: Can Medidata Solutions Save Drug Companies Billions?
Forbes
Monday, February 17, 2014 - 11:11am
tags:
software, Medidata Solutions
Rumor mill: Apple's working on device to predict heart attacks
Mass Device
Monday, February 17, 2014 - 10:17am
tags:
Apple, heart attacks, devices
Biogen Idec Chairman: New Boss Same as the Old Boss?
Yahoo/24-7 Wall St
Monday, February 17, 2014 - 10:16am
tags:
Biogen Idec, Stelios Papadopoulos

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.